Menu
24/06/2003
£50m funding unveiled for NHS gene research
The government is set to promote the development of genetics within the NHS following its decision to plough £50 million into the scheme over the next three years.
The White Paper 'Our Inheritance, Our Future - Realising the potential of genetics in the NHS' sets out the government's strategy.
The paper proposes that:
Secretary of State for Health John Reid said: "Our vision is for the NHS to lead the world in taking maximum advantage of the safe, effective and ethical application of the new genetic knowledge and technologies for all patients as soon as they become available. At the same time this government will make sure there are safeguards and controls in place to guard against inappropriate use of developments in genetics."
(GMcG)
The White Paper 'Our Inheritance, Our Future - Realising the potential of genetics in the NHS' sets out the government's strategy.
The paper proposes that:
- £18 million will be spent on upgrading genetics laboratories to prepare them for the expansion in genetic testing
- more than £7 million will be spent on new initiatives to develop genetics based healthcare
- investment of up to £3 million will be used to support gene therapy research on single gene disorders and a further £2.5 million over five years to support gene therapy research for cystic fibrosis - the most common single gene disorder in the UK
- £4 million will also be spent on gene therapy manufacturing facilities
- more than £4 million will be spent on pharmacogenetics research on commonly used drugs, and a new university Chair and department in pharmacogenetics will be set up.
Secretary of State for Health John Reid said: "Our vision is for the NHS to lead the world in taking maximum advantage of the safe, effective and ethical application of the new genetic knowledge and technologies for all patients as soon as they become available. At the same time this government will make sure there are safeguards and controls in place to guard against inappropriate use of developments in genetics."
(GMcG)
Related UK National News Stories
Click here for the latest headlines.
02 August 2004
Gene therapy trial for cancer patients gets green light
The green light has been given for a large clinical trial of a new gene therapy treatment for patients with Glioma - one of the most aggressive types of brain tumours for which there is currently no cure. The new gene therapy treatment involves injecting Herpes simplex virus into the brain tumours of Glioma patients.
Gene therapy trial for cancer patients gets green light
The green light has been given for a large clinical trial of a new gene therapy treatment for patients with Glioma - one of the most aggressive types of brain tumours for which there is currently no cure. The new gene therapy treatment involves injecting Herpes simplex virus into the brain tumours of Glioma patients.
29 March 2004
Research in genetic disorders gets £4m funding boost
The government has said that it will plough £3 million into clinical trials and research into the genetic disorders of haemophilia, muscular dystrophy and childhood blindness. A further £1 million will be used to support research into the long-term safety of some techniques used in gene therapy, the Health Secretary John Reid said today.
Research in genetic disorders gets £4m funding boost
The government has said that it will plough £3 million into clinical trials and research into the genetic disorders of haemophilia, muscular dystrophy and childhood blindness. A further £1 million will be used to support research into the long-term safety of some techniques used in gene therapy, the Health Secretary John Reid said today.
10 July 2009
Gene Defect Linked To Allergy, BMJ Finds
Defects in a particular gene - the filaggrin gene - are associated with a significantly increased risk of developing allergic disorders such as eczema, rhinitis, and asthma, concludes a study published on bmj.com today. Allergic diseases have increased in recent decades and now affect up to one in three children in economically developed countries.
Gene Defect Linked To Allergy, BMJ Finds
Defects in a particular gene - the filaggrin gene - are associated with a significantly increased risk of developing allergic disorders such as eczema, rhinitis, and asthma, concludes a study published on bmj.com today. Allergic diseases have increased in recent decades and now affect up to one in three children in economically developed countries.
04 January 2005
£2.5m to support cystic fibrosis gene therapy research
Health Minister, Lord Warner, has announced the winning bids for £2.5 million to support further research into gene therapy for cystic fibrosis (CF).
£2.5m to support cystic fibrosis gene therapy research
Health Minister, Lord Warner, has announced the winning bids for £2.5 million to support further research into gene therapy for cystic fibrosis (CF).
12 October 2015
£200m Polar Research Ship To Be Built
The preferred bidder to construct a £200m state-of-the-art polar research ship has been named. Cammell Laird in Birkenhead has been selected as the preferred bidder for the project which will help the UK remain at the forefront of climate and ocean research.
£200m Polar Research Ship To Be Built
The preferred bidder to construct a £200m state-of-the-art polar research ship has been named. Cammell Laird in Birkenhead has been selected as the preferred bidder for the project which will help the UK remain at the forefront of climate and ocean research.
-
Northern Ireland WeatherThis Evening and Tonight:Dry for much of the night. Clear periods at first with mist and fog re-forming, Becoming cloudy later tonight with patchy drizzle towards the North Coast. Minimum temperature 3 °C.
